References
Lewander T. Res Clin Forums 15: 55–67, 1993
Wadworth AN, Heel RC. Drugs 40: 863–879, 1990
Holm A-C, et al. Drug Saf 8: 445–456, 1993
Kane JM. Drugs 46: 585–593, 1993
Anon. F-D-C Reports ‘Pink Sheet’ 55: T&G-3, Nov 8 1993
Kane MD, et al. Arch Gen Psychiatry 45: 789–796, 1988
Pickar D, et al. Arch Gen Psychiatry 49: 345–353, 1992
Anon. Drugs & Therapy Perspectives 1: 7, 5 Jul 1993
Scurlock HJ, Robinson PH. J Drug Dev 6: 71–72, 1993
Leysen JE, et al. Psychopharmacol 112 (Suppl.): S40–S54, 1993
Lapierre YD, et al. Acta Psychiatr Scand 82 (Suppl. 358): 72–77, 1990
Lewander T, et al. Acta Psychiatr Scand 82 (Suppl. 358): 92–98, 1990
Chouinard G. Acta Psychiatr Scand 82 (Suppl. 358): 111–119, 1990
Pflug B, et al. Acta Psychiatr Scand 82 (Suppl. 358): 181–185, 1990
King DJ, et al. Br J Clin Pharmacol 31: 220P–221P, 1991
Walinder J, Holm A-C. Acta Psychiatr Scand 82 (Suppl. 358): 158–163, 1990
Karlsson I, et al. Eur Neuropsychopharmacol 3 (Spec. Issue): 401, 1993
Chouinard G. J Clin Psychopharmacol 7: 159–164, 1987
Morrison D, et al. Acta Psychiatr Scand 82 (Suppl. 358): 158–163, 1990
Anon. Inpharma 911: 21, 1993
Anon. Scrip 1873: 22, 1993
Rights and permissions
About this article
Cite this article
Remoxipride: consider in patients intolerant of or resistant to haloperidol. Drugs Ther. Perspect 3, 4–7 (1994). https://doi.org/10.2165/00042310-199403010-00002
Published:
Issue Date:
DOI: https://doi.org/10.2165/00042310-199403010-00002